Advertisement
Advertisement
TMO
Thermo Fisher Scientific, Inc.
469.21
USDSponsored
-9.75
-2.04%
May 01, 15:59 UTC -4
Closed
After-Market
469.00
-0.21
-0.05%
TMO Earnings Reports
Positive Surprise Ratio
TMO beat 35 of 41 last estimates.
85%
Next Report
Date of Next Report
Jul 21, 2026
Estimate for Q2 26 (Revenue/ EPS)
$11.78B
/$5.78
Implied change from Q1 26 (Revenue/ EPS)
+7.02%
/+6.25%
Implied change from Q2 25 (Revenue/ EPS)
+8.50%
/+7.84%
Thermo Fisher Scientific, Inc. earnings per share and revenue
On Apr 23, 2026, TMO reported earnings of 5.44 USD per share (EPS) for Q1 26, beating the estimate of 5.28 USD, resulting in a 2.84% surprise. Revenue reached 11.01 billion, compared to an expected 10.96 billion, with a 0.40% difference. The market reacted with a -9.20% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 18 analysts forecast an EPS of 5.78 USD, with revenue projected to reach 11.78 billion USD, implying an increase of 6.25% EPS, and increase of 7.02% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Edwards Lifesciences Corp
Report Date
Apr 23, 2026 For Q1 26
Estimate
$0.74
Actual
$0.78
Surprise
+4.17%
DexCom, Inc.
Report Date
Apr 30, 2026 For Q1 26
Estimate
$0.47
Actual
$0.56
Surprise
+17.03%
Glaukos Corporation
Report Date
Apr 29, 2026 For Q1 26
Estimate
-$0.27
Actual
-$0.18
Surprise
+35.30%
Integer Holdings Corporation
Report Date
Apr 30, 2026 For Q1 26
Estimate
$1.21
Actual
$1.20
Surprise
-0.84%
Axogen, Inc. Common Stock
Report Date
Apr 28, 2026 For Q1 26
Estimate
$0.07
Actual
$0.07
Surprise
-4.50%
PROCEPT BioRobotics Corporation Common Stock
Report Date
Apr 29, 2026 For Q1 26
Estimate
-$0.56
Actual
-$0.56
Surprise
+1.34%
iRadimed Corporation
Report Date
May 01, 2026 For Q1 26
Estimate
$0.45
Actual
$0.49
Surprise
+7.95%
Opko Health Inc.
Report Date
Apr 28, 2026 For Q1 26
Estimate
-$0.07
Actual
-$0.07
Surprise
+0.99%
Beta Bionics, Inc. Common Stock
Report Date
Apr 21, 2026 For Q1 26
Estimate
-$0.49
Actual
-$0.49
Surprise
+1.69%
OrthoPediatrics Corp. Common Stock
Report Date
Apr 30, 2026 For Q1 26
Estimate
-$0.48
Actual
-$0.42
Surprise
+13.53%
FAQ
What were Thermo Fisher Scientific, Inc.'s earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Thermo Fisher Scientific, Inc. reported EPS of $5.44, beating estimates by 2.84%, and revenue of $11.01B, 0.4% above expectations.
How did the market react to Thermo Fisher Scientific, Inc.'s Q1 2026 earnings?
The stock price moved down -9.2%, changed from $513.98 before the earnings release to $466.70 the day after.
When is Thermo Fisher Scientific, Inc. expected to report next?
The next earning report is scheduled for Jul 21, 2026.
What are the forecasts for Thermo Fisher Scientific, Inc.'s next earnings report?
Based on 18
analysts, Thermo Fisher Scientific, Inc. is expected to report EPS of $5.78 and revenue of $11.78B for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement